The NYSE Arca Pharmaceutical Index (DRG) is a market-capitalization weighted index designed to represent a cross section of widely held, highly capitalized companies involved in various phased of the pharmaceutical industry. The DRG Index was developed with a base value of 200.00 on July 31, 1991. (The index value was later split 2-for-1 on March 23, 1999).
Sterling Market Commentary for Tuesday March 27th, 2012
A Look at Monday’s Market: The overall market moved sharply higher in a broad based move that saw every index I track move higher on […]